Eric Kelsic

Company: Dyno Therapeutics

Job title: Co-Founder & Chief Executive Officer

Seminars:

Machine-guided design and optimization of AAV gene therapies 12:00 pm

Using machine learning to solve gene delivery challenges to the eye, muscle, and CNS Demonstrating the capabilities of next-gen AAV vectors in NHP studies Emerging opportunities applying AI to general purpose multi-property optimization for in vivo effectivenessRead more

day: Day 1- Clinical 1